Search Results - Maria R Baer
- Showing 1 - 20 results of 24
- Go to Next Page
-
1
Post-HCT gilteritinib outweighs conditioning in NPM1m FLT3-ITD AML by Aaron James Stonestrom, Maria R. Baer
Published in Blood Advances (2025-10-01)Get full text
Article -
2
-
3
-
4
-
5
Pim-1 kinase phosphorylates and stabilizes 130 kDa FLT3 and promotes aberrant STAT5 signaling in acute myeloid leukemia with FLT3 internal tandem duplication. by Karthika Natarajan, Yingqiu Xie, Mehmet Burcu, Douglas E Linn, Yun Qiu, Maria R Baer
Published in PLoS ONE (2013-01-01)Get full text
Article -
6
-
7
-
8
-
9
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes by Amy J. Davidoff, Sheila Weiss Smith, Maria R. Baer, Xuehua Ke, Jason M. Bierenbaum, Franklin Hendrick, Diane L. McNally, Steven D. Gore
Published in Haematologica (2012-01-01)Get full text
Article -
10
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndrome by Jorge E. Cortes, Jay Yang, Gail J. Roboz, Shira N. Dinner, Eunice S. Wang, Andrew H. Wei, Hua Tian, Francois di Trapani, Maria R. Baer, William Donnellan, Justin M. Watts
Published in Blood Advances (2025-10-01)Get full text
Article -
11
Quality‐Adjusted Time Without Symptoms of Disease or Toxicity (Q‐TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia: A Comparison... by Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Vanderson Rocha, Cristina Papayannidis, Jessica T. Leonard, Maria R. Baer, Jose‐Maria Ribera, James McCloskey, Jianxiang Wang, Deepali Rane, Shien Guo
Published in Cancer Medicine (2025-04-01)Get full text
Article -
12
Rapid Detection of <i>PML::RARA</i> Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive Sampling by William Middlezong, Victoria Stinnett, Michael Phan, Brian Phan, Laura Morsberger, Melanie Klausner, Jen Ghabrial, Natalie DeMetrick, Jing Zhu, Trisha James, Aparna Pallavajjala, Christopher D. Gocke, Maria R. Baer, Ying S. Zou
Published in Biomolecules (2024-12-01)Get full text
Article -
13
Impact of <i>FLT3</i>-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study by Elizabeth M. Corley, Moaath K. Mustafa Ali, Hanan Alharthy, Kathryn A. F. Kline, Danielle Sewell, Jennie Y. Law, Seung Tae Lee, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Ashkan Emadi
Published in Biology (2022-06-01)Get full text
Article -
14
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001 by Geoffrey L. Uy, Sumithra J. Mandrekar, Kristina Laumann, Guido Marcucci, Weiqiang Zhao, Mark J. Levis, Heidi D. Klepin, Maria R. Baer, Bayard L. Powell, Peter Westervelt, Daniel J. DeAngelo, Wendy Stock, Ben Sanford, William G. Blum, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson
Published in Blood Advances (2017-01-01)Get full text
Article -
15
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification by Andrew Y. Li, Sarah M. Kashanian, Bryan C. Hambley, Kyle Zacholski, Vu H. Duong, Firas El Chaer, Noa G. Holtzman, Ivana Gojo, Jonathan A. Webster, Kelly J. Norsworthy, Bruce Douglas Smith, Amy E. DeZern, Mark J. Levis, Maria R. Baer, Farin Kamangar, Gabriel Ghiaur, Ashkan Emadi
Published in Biology (2021-03-01)Get full text
Article -
16
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phas... by Jorge E. Cortes, Gail J. Roboz, Maria R. Baer, Brian A. Jonas, Gary J. Schiller, Karen Yee, P. Brent Ferrell, Jay Yang, Eunice S. Wang, William G. Blum, Alice Mims, Hua Tian, Aaron Sheppard, Stéphane de Botton, Pau Montesinos, Antonio Curti, Justin M. Watts, the Olutasidenib Combination Therapy Study Group
Published in Journal of Hematology & Oncology (2025-01-01)Get full text
Article -
17
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission by Sumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek, Ann-Kathrin Eisfeld, Deedra Nicolet, Lisa J. Sterling, Heiko Becker, Klaus H. Metzeler, Dimitrios Papaioannou, Bayard L. Powell, Jonathan E. Kolitz, Joseph O. Moore, Maria R. Baer, Gail J. Roboz, Richard M. Stone, John C. Byrd, Andrew J. Carroll, Clara D. Bloomfield
Published in Blood Advances (2018-07-01)Get full text
Article -
18
P367: LONG-TERM OUTCOMES OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH BREXUCABTAGENE AUTOLEUCEL IN ZUMA-3 BY AGE, PRIOR THERAPIES, AND SUB... by Bijal Shah, Ryan D. Cassaday, Jae H. Park, Roche Houot, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Kristen M. O’dwyer, Maria R. Baer, Gary J. Schiller, Mehrdad Abedi, Monique C. Minnema, Patrick Stiff, Lang Zhou, Tsveta Hadjivassileva, Rita Damico Khalid, Armin Ghobadi
Published in HemaSphere (2023-08-01)Get full text
Article -
19
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acu... by Heiko Becker, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Klaus H. Metzeler, Susan P. Whitman, Sebastian Schwind, Jessica Kohlschmidt, Yue-Zhong Wu, Bayard L. Powell, Thomas H. Carter, Jonathan E. Kolitz, Meir Wetzler, Andrew J. Carroll, Maria R. Baer, Joseph O. Moore, Michael A. Caligiuri, Richard A. Larson, Guido Marcucci, Clara D. Bloomfield
Published in Haematologica (2011-10-01)Get full text
Article -
20
Increased body mass index is a risk factor for acute promyelocytic leukemia by Sarah M. Kashanian, Andrew Y. Li, Moaath Mustafa Ali, Mark E. Sutherland, Vu H. Duong, Bryan C. Hambley, Kyle Zacholski, Firas El Chaer, Noa G. Holtzman, Mohammad Imran, Ciera L. Patzke, Jonathan Cornu, Alison Duffy, Amy E. Dezern, Ivana Gojo, Kelly J. Norsworthy, Mark J. Levis, B. Douglas Smith, Maria R. Baer, Gabriel Ghiaur, Ashkan Emadi
Published in eJHaem (2021-02-01)Get full text
Article
